Cargando…

An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures

A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nshimyumukiza, Léon, Durand, Audrey, Gagnon, Mathieu, Douville, Xavier, Morin, Suzanne, Lindsay, Carmen, Duplantie, Julie, Gagné, Christian, Jean, Sonia, Giguère, Yves, Dodin, Sylvie, Rousseau, François, Reinharz, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580046/
https://www.ncbi.nlm.nih.gov/pubmed/22991210
http://dx.doi.org/10.1002/jbmr.1758
_version_ 1782260200015659008
author Nshimyumukiza, Léon
Durand, Audrey
Gagnon, Mathieu
Douville, Xavier
Morin, Suzanne
Lindsay, Carmen
Duplantie, Julie
Gagné, Christian
Jean, Sonia
Giguère, Yves
Dodin, Sylvie
Rousseau, François
Reinharz, Daniel
author_facet Nshimyumukiza, Léon
Durand, Audrey
Gagnon, Mathieu
Douville, Xavier
Morin, Suzanne
Lindsay, Carmen
Duplantie, Julie
Gagné, Christian
Jean, Sonia
Giguère, Yves
Dodin, Sylvie
Rousseau, François
Reinharz, Daniel
author_sort Nshimyumukiza, Léon
collection PubMed
description A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings.
format Online
Article
Text
id pubmed-3580046
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Wiley Subscription Services, Inc., A Wiley Company
record_format MEDLINE/PubMed
spelling pubmed-35800462013-02-25 An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures Nshimyumukiza, Léon Durand, Audrey Gagnon, Mathieu Douville, Xavier Morin, Suzanne Lindsay, Carmen Duplantie, Julie Gagné, Christian Jean, Sonia Giguère, Yves Dodin, Sylvie Rousseau, François Reinharz, Daniel J Bone Miner Res Original Articles A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings. Wiley Subscription Services, Inc., A Wiley Company 2013-02 /pmc/articles/PMC3580046/ /pubmed/22991210 http://dx.doi.org/10.1002/jbmr.1758 Text en Copyright © 2013 American Society for Bone and Mineral Research http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Articles
Nshimyumukiza, Léon
Durand, Audrey
Gagnon, Mathieu
Douville, Xavier
Morin, Suzanne
Lindsay, Carmen
Duplantie, Julie
Gagné, Christian
Jean, Sonia
Giguère, Yves
Dodin, Sylvie
Rousseau, François
Reinharz, Daniel
An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
title An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
title_full An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
title_fullStr An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
title_full_unstemmed An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
title_short An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
title_sort economic evaluation: simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580046/
https://www.ncbi.nlm.nih.gov/pubmed/22991210
http://dx.doi.org/10.1002/jbmr.1758
work_keys_str_mv AT nshimyumukizaleon aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT durandaudrey aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT gagnonmathieu aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT douvillexavier aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT morinsuzanne aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT lindsaycarmen aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT duplantiejulie aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT gagnechristian aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT jeansonia aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT giguereyves aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT dodinsylvie aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT rousseaufrancois aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT reinharzdaniel aneconomicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT nshimyumukizaleon economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT durandaudrey economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT gagnonmathieu economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT douvillexavier economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT morinsuzanne economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT lindsaycarmen economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT duplantiejulie economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT gagnechristian economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT jeansonia economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT giguereyves economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT dodinsylvie economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT rousseaufrancois economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures
AT reinharzdaniel economicevaluationsimulationofthecosteffectivenessandcostutilityofuniversalpreventionstrategiesagainstosteoporosisrelatedfractures